Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04114227 · ClinicalTrials.gov registry record · NA

Acceptance and Commitment Therapy vs. Supportive Psychotherapy With Cystic Fibrosis Patients

A NA study, sponsored by Thomas Jefferson University.

Completed
Registry status
NA
Development phase
146
Enrollment target

NCT04114227 is a NA study that has completed, run by Thomas Jefferson University. The registered enrollment target is 146 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04114227, a NA study, has completed, sponsored by Thomas Jefferson University.

COMPLETED
Registry status
NA
Development phase
146 participants
Enrollment target

Study Summary

The objective of the study is to assess the utility of "Acceptance and Commitment Therapy" (ACT) in which subjects learn new ways to manage uncomfortable experiences and feelings and to engage in positive behaviors, over "Supportive Psychotherapy" in which subjects talk about their experiences to date in a cohort of adult Cystic Fibrosis patients. The hypothesis is that six telehealth/webcam sessions of ACT will lead to an improvement in medication and visit compliance, as well as an overall improved sense of well-being and coping skills, particularly as compared with 6 telehealth/webcam sessions of supportive psychotherapy.

Interventions

  • BEHAVIORAL Acceptance and Commitment Therapy adapted for Cystic Fibrosis (ACT with CF)
  • BEHAVIORAL Supportive Psychotherapy (Treatment as Usual Control)

Trial Details

FieldValue
Enrollment Target 146 participants
Start Date 2019-07-01
Est. Completion 2023-10-31
Phase NA

Sponsor

Thomas Jefferson University

292 total trials

What the Registry Record Tells You About NCT04114227

The ClinicalTrials.gov registry entry for NCT04114227 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 146 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Acceptance and Commitment Therapy adapted for Cystic Fibrosis (ACT with CF) is the first listed.

NCT04114227 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04114227 about?

NCT04114227 is a clinical study titled "Acceptance and Commitment Therapy vs. Supportive Psychotherapy With Cystic Fibrosis Patients". The objective of the study is to assess the utility of "Acceptance and Commitment Therapy" (ACT) in which subjects learn new ways to manage uncomfortable experiences and feelings and to engage in positive behaviors, over "Supportive Psychotherapy" in which subjects talk about their experiences to da...

What is the current status of trial NCT04114227?

This trial is currently completed. It is a NA study. The enrollment target is 146 participants. The study started on 2019-07-01. Estimated completion is 2023-10-31.

What interventions are being tested in trial NCT04114227?

The interventions under investigation include: Acceptance and Commitment Therapy adapted for Cystic Fibrosis (ACT with CF) (BEHAVIORAL), Supportive Psychotherapy (Treatment as Usual Control) (BEHAVIORAL).

Who is sponsoring clinical trial NCT04114227?

This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.